Novel NRCT-101SR shown in previous human studies to be effective and well-tolerated with no side effects
Read Press Releaseā Faro Health Inc. strengthens its management team, appointing Kimberly C. Pospahala as Vice President of Commercial to accelerate go-to-market efforts to digitally transform clinical protocol design ā Scott Chetham, Ph.D., Co-Founder & CEO of Faro Health, Inc., will present at the SCOPE Conference on Feb. 9, 2022
Read Press ReleaseGb Sciences' collaboration with MSU has received media coverage across the country, starting with an interview from WLNS-TV in Lansing, Michigan, and interviews with Gb Sciences in the magazines 'Cannabis Business Times' and 'Hemp Grower'
Read Press ReleaseWith the addition of these new locations, Cordant's managed medication-assisted treatment (MAT) pharmacy program Cordant Pharmacy Solutionsā¢ now serves more than 17,000 patients in 12 states
Read Press ReleaseCompanies have also entered into a joint development agreement which will merge technologies with the aim to bring innovative products for consumer electronics market.
Read Press ReleasePresentation to include clinical data from Aronora's phase 2 study of AB002, a first-in-class protein C activator enzyme that is being developed for the treatment and prevention of thrombotic and inflammatory diseases.
Read Press ReleaseNew digital pathology, quantitative image analysis and quantitative AI method for liver tissues is presented for the continuous assessment of the histological phenotype(s) of fibrosis, including severity and regression of fibrosis in Human in-vitro 3D NASH Spheroid models, NASH rodent models, Clinical Phase2b NASH Studies at the Liver Meeting Digital Experienceā¢ 2021
Read Press ReleaseThe biopharma technology company's AI-driven PhAROSā¢ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council of Canada.
Read Press ReleaseDemco Automation develops automated manufacturing systems using new robotic technologies to a growing list of industries, including life science, pharmaceuticals, biotech, medical device, defense, aerospace, electronics, commercial/industrial products, semiconductors, and consumer products.
Read Press ReleaseLFB, a global bio-pharmaceutical group that develops and markets therapeutics for patients with chronic and serious diseases in 30 countries, opens its second location in Florida as 'LFB Plasma.'
Read Press ReleaseAcquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use, allowing Pace to support a growing number of clients throughout the drug development process.
Read Press ReleaseOffering pharmacies, other healthcare providers, and PBMs a comprehensive portfolio of services, including formulary management, on-demand pharmacy, benefit administration, and rebate aggregation
Read Press Release